．

Material Information - Hong Kong Department of Health has Approved the New Drug Registration of BESREMi (Ropeginterferon alfa-2b) for PV

Oct 6, 2025

20251006 本公司新藥BESREMi獲香港衛生署核准使用於成人真性紅血球增多症（PV）(EN).pdf

Download